Found: 33
Select item for more details and to access through your institution.
Impact of tumour RAS/BRAF status in a first-line study of panitumumab + FOLFIRI in patients with metastatic colorectal cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Combination of treosulfan, fludarabine and cytarabine as conditioning in patients with acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative neoplasms.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 10, p. 2599, doi. 10.1007/s00432-021-03836-8
- By:
- Publication type:
- Article
First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2012, v. 138, n. 1, p. 65, doi. 10.1007/s00432-011-1061-6
- By:
- Publication type:
- Article
Impact of Primary Tumour Location and Early Tumour Shrinkage on Outcomes in Patients with RAS Wild-Type Metastatic Colorectal Cancer Following First-Line FOLFIRI Plus Panitumumab.
- Published in:
- Drugs in R&D, 2019, v. 19, n. 3, p. 267, doi. 10.1007/s40268-019-0278-8
- By:
- Publication type:
- Article
Current therapy of advanced colorectal cancer according to RAS/RAF mutational status.
- Published in:
- Cancer & Metastasis Reviews, 2020, v. 39, n. 4, p. 1143, doi. 10.1007/s10555-020-09913-7
- By:
- Publication type:
- Article
Relevance of neoadjuvant and adjuvant treatment for patients with resectable liver metastases of colorectal carcinoma.
- Published in:
- Langenbeck's Archives of Surgery, 1999, v. 384, n. 4, p. 328, doi. 10.1007/s004230050210
- By:
- Publication type:
- Article
The Screening and COnsensus Based on Practices and Evidence (SCOPE) Program-Results of a Survey on Daily Practice Patterns for Patients with mCRC.
- Published in:
- Current Oncology, 2021, v. 28, n. 3, p. 2097, doi. 10.3390/curroncol28030194
- By:
- Publication type:
- Article
All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 3, p. 268, doi. 10.1007/s00262-005-0021-x
- By:
- Publication type:
- Article
Endpoints in Adjuvant Treatment Trials: A Systematic Review of the Literature in Colon Cancer and Proposed Definitions for Future Trials.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 13, p. 998, doi. 10.1093/jnci/djm024
- By:
- Publication type:
- Article
Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper.
- Published in:
- Oncology Research & Treatment, 2020, v. 43, n. 11, p. 628, doi. 10.1159/000510258
- By:
- Publication type:
- Article
Long‐term outcome in patients with mantle cell lymphoma following high‐dose therapy and autologous stem cell transplantation.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 2, p. 220, doi. 10.1111/ejh.13985
- By:
- Publication type:
- Article
Herpes zoster prophylaxis with low‐dose acyclovir in patients with malignant lymphoma and multiple myeloma treated with autologous stem cell transplantation.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 3, p. 298, doi. 10.1111/ejh.13810
- By:
- Publication type:
- Article
Long‐term outcome in patients with follicular lymphoma following high‐dose therapy and autologous stem cell transplantation.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 5, p. 543, doi. 10.1111/ejh.13691
- By:
- Publication type:
- Article
Cardiotoxicity of 5-fluorouracil in combination with folinic acid in patients with gastrointestinal cancer.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Cetuximab: A Viewpoint by Patrick Schöffski1 and Claus-Henning Köhne2.
- Published in:
- Drugs, 2004, v. 64, n. 1, p. 119
- By:
- Publication type:
- Article
Correction to: TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer.
- Published in:
- BMC Cancer, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12885-021-08656-0
- By:
- Publication type:
- Article
TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer.
- Published in:
- BMC Cancer, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12885-021-08656-0
- By:
- Publication type:
- Article
Long-term remissions in patients with early relapse of diffuse large B-cell lymphoma following high-dose chemotherapy, autologous stem cell transplantation, and radiotherapy of residual disease.
- Published in:
- Strahlentherapie und Onkologie, 2022, v. 198, n. 1, p. 39, doi. 10.1007/s00066-021-01868-0
- By:
- Publication type:
- Article
Vinflunine in the treatment of advanced urothelial cancer: clinical evidence and experience.
- Published in:
- Therapeutic Advances in Urology, 2017, v. 9, n. 1, p. 28, doi. 10.1177/1756287216677903
- By:
- Publication type:
- Article
Relationships Between Kohne Category/Baseline Tumor Load and Early Tumor Shrinkage, Depth of Response, and Outcomes in Metastatic Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2021, v. 20, n. 4, p. 305, doi. 10.1016/j.clcc.2021.05.007
- By:
- Publication type:
- Article
Survival Outcomes in Patients With RAS Wild Type Metastatic Colorectal Cancer Classified According to Köhne Prognostic Category and BRAF Mutation Status.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Panitumumab in combination with cytotoxic chemotherapy for the treatment of metastatic colorectal carcinoma.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Emerging role of bevacizumab in management of patients with symptomatic hepatic involvement in Hereditary Hemorrhagic Telangiectasia.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 11, p. E641, doi. 10.1002/ajh.24878
- By:
- Publication type:
- Article
Letter to the Editor.
- Published in:
- Oncology, 2005, v. 68, n. 2/3, p. 162, doi. 10.1159/000086959
- By:
- Publication type:
- Article
The Role of New Agents in the Treatment of Colorectal Cancer.
- Published in:
- Oncology, 2004, v. 66, n. 1, p. 1, doi. 10.1159/000076329
- By:
- Publication type:
- Article
Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil plus Folinic Acid in Combination with Mitomycin C for the Treatment of Advanced Gastric Cancer.
- Published in:
- Oncology, 2000, v. 59, n. 1, p. 14, doi. 10.1159/000012130
- By:
- Publication type:
- Article
Chemotherapy with Targeted Agents for the Treatment of Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2009, v. 14, n. 5, p. 478, doi. 10.1634/theoncologist.2008-0202
- By:
- Publication type:
- Article
Chemotherapy in Elderly Patients with Colorectal Cancer.
- Published in:
- Oncologist, 2008, v. 13, n. 4, p. 390, doi. 10.1634/theoncologist.2007-0043
- By:
- Publication type:
- Article
Matrix-comparative genomic hybridization from multicenter formalin-fixed paraffin-embedded colorectal cancer tissue blocks.
- Published in:
- BMC Cancer, 2007, v. 7, p. 58, doi. 10.1186/1471-2407-7-58
- By:
- Publication type:
- Article